TG Therapeutics, Inc. earnings per share and revenue
On 03 de nov. de 2025, TGTX reported earnings of 0.16 USD per share (EPS) for Q3 25, missing the estimate of 0.22 USD, resulting in a -28.70% surprise. Revenue reached 161.71 milhão, compared to an expected 155.21 milhão, with a 4.19% difference. The market reacted with a -3.13% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were TG Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, TG Therapeutics, Inc. reported EPS of $0.16, missing estimates by -28.7%, and revenue of $161.71M, 4.19% above expectations.
How did the market react to TG Therapeutics, Inc.'s Q3 2025 earnings?
The stock price moved down -3.13%, changed from $34.78 before the earnings release to $33.69 the day after.
When is TG Therapeutics, Inc. expected to report next?
The next earning report is scheduled for --.
What are the forecasts for TG Therapeutics, Inc.'s next earnings report?
Based on --
analistas, TG Therapeutics, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.